90 related articles for article (PubMed ID: 26773402)
1. Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome.
Denimal D; Nguyen A; Pais de Barros JP; Bouillet B; Petit JM; Vergès B; Duvillard L
Atherosclerosis; 2016 Mar; 246():106-14. PubMed ID: 26773402
[TBL] [Abstract][Full Text] [Related]
2. Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration.
Denimal D; Pais de Barros JP; Petit JM; Bouillet B; Vergès B; Duvillard L
Atherosclerosis; 2015 Aug; 241(2):752-60. PubMed ID: 26142685
[TBL] [Abstract][Full Text] [Related]
3. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
Camont L; Lhomme M; Rached F; Le Goff W; Nègre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Chapman MJ; Kontush A
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2715-23. PubMed ID: 24092747
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome.
Ng TW; Ooi EM; Watts GF; Chan DC; Weir JM; Meikle PJ; Barrett PH
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2335-40. PubMed ID: 25140396
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
Granot E
Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
[TBL] [Abstract][Full Text] [Related]
6. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.
Sutter I; Velagapudi S; Othman A; Riwanto M; Manz J; Rohrer L; Rentsch K; Hornemann T; Landmesser U; von Eckardstein A
Atherosclerosis; 2015 Aug; 241(2):539-46. PubMed ID: 26093887
[TBL] [Abstract][Full Text] [Related]
7. Role and metabolism of high density lipoprotein subfractions--analysis of serum HDL2-cholesterol and HDL3-cholesterol in patients with various diseases by high performance liquid chromatography.
Tanaka A
Bull Tokyo Med Dent Univ; 1982 Dec; 29(4):131-7. PubMed ID: 6959738
[TBL] [Abstract][Full Text] [Related]
8. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
[TBL] [Abstract][Full Text] [Related]
9. [Subfractions of high density lipoproteins in relation to age].
Richter V; Rassoul F; Purcz T; Faki R
Z Gerontol; 1990; 23(1):50-5. PubMed ID: 2327147
[TBL] [Abstract][Full Text] [Related]
10. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the indices affecting the phospholipid structure of high density lipoprotein subfractions in ischemic heart disease].
Pham Thi My; Torkhovskaia TI; Ozerova IN; Polesskiĭ VA; Kurdanov KhA
Vopr Med Khim; 1981; 27(5):701-6. PubMed ID: 7314590
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the individual phospholipids and their fatty acids in serum and high-density lipoprotein of the renal patient on long-term maintenance hemodialysis.
Chapkin RS; Haberstroh B; Liu T; Holub BJ
J Lab Clin Med; 1983 May; 101(5):726-35. PubMed ID: 6833842
[TBL] [Abstract][Full Text] [Related]
13. Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities.
Denimal D; Benanaya S; Monier S; Simoneau I; Pais de Barros JP; Le Goff W; Bouillet B; Vergès B; Duvillard L
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3816-e3823. PubMed ID: 35647758
[TBL] [Abstract][Full Text] [Related]
14. [Levels of HDL cholesterol and the HDL2 and HDL3 subfractions in newly detected type 2 diabetes].
Brunová J; Válek J; Grafnetter D; Karasová L
Vnitr Lek; 1989 Mar; 35(3):292-8. PubMed ID: 2734999
[TBL] [Abstract][Full Text] [Related]
15. [Changes in HDL subfractions in patients with type I diabetes mellitus before and after metabolic control].
Pacifico A; Cherchi GM; Baggi MA; Deiana MG; Maioli M
Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1618-24. PubMed ID: 6365116
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of oestrogen and raloxifene effects on the phospholipid composition of high density lipoproteins in healthy postmenopausal women.
Piperi C; Kalofoutis C; Papapanagiotou A; Skenderi C; Kalofoutis A
J Obstet Gynaecol; 2004 Jan; 24(1):52-7. PubMed ID: 14675982
[TBL] [Abstract][Full Text] [Related]
17. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
Artery; 1993; 20(1):1-18. PubMed ID: 8447724
[TBL] [Abstract][Full Text] [Related]
18. The HDL2/HDL3 ratio in menopause.
Ushiroyama T; Sakuma K; Ikeda A; Ueki M
Int J Gynaecol Obstet; 2005 Mar; 88(3):303-8. PubMed ID: 15733886
[TBL] [Abstract][Full Text] [Related]
19. Determination of cholesterol and phospholipids of HDL2, HDL3 and VHDL in patients with atherosclerosis and diabetes mellitus.
Kajiyama G; Nakagawa M; Takata K; Nakao S; Miyoshi A
Hiroshima J Med Sci; 1981 Sep; 30(3):175-82. PubMed ID: 7298368
[No Abstract] [Full Text] [Related]
20. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
